NSC139105
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2006-01-12T13:09:18Z | |
dc.date.available | 2006-01-12T13:09:18Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2006-01-12T13:09:18Z | |
dc.identifier | NSC139105 | en_GB |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/109269 | |
dc.format.extent | 8703 bytes | |
dc.format.extent | 7497 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.format.mimetype | chemical/x-cml | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC139105 | en_GB |
dc.title.alternative | Baker's Antifol soluble | en_GB |
dc.title.alternative | BAF | en_GB |
dc.title.alternative | Ethanesulfonic acid, compd. with .alpha.-[2-chloro-4-(4,6-diamino-2, 2-dimethyl-s-triazin-1(2H)-yl)-phenoxy]-N,N-dimethyl-m-toluamide | en_GB |
dc.title.alternative | Ethanesulfonic acid, compd. with 3-[[2-chloro-4-(4,6-diamino-2, 2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]methyl]-N, N-dimethylbenzamide (1:1) (9CI) | en_GB |
dc.title.alternative | NSC 139105 | en_GB |
dc.title.alternative | Triazinate | en_GB |
dc.title.alternative | TZT | en_GB |
dc.type | Chemical Structures | en_GB |
dc.identifier.inchikey | WJHBDAIAIDOONY-UHFFFAOYSA-N | |
dc.identifier.inchi | InChI=1S/C21H25ClN6O2/c1-21(2)26-19(23)25-20(24)28(21)15-8-9-17(16(22)11-15)30-12-13-6-5-7-14(10-13)18(29)27(3)4/h5-11H,12H2,1-4H3,(H4,23,24,25,26) | |
dc.identifier.ichi | C21H25ClN6O2,1H3-21(2H3)26-19(23H2)25-20(24H2)28(21)15-8H-9H-17(16(22)11H-15)30-12H2-13-6H-5H-7H-14(10H-13)18(29)27(3H3)4H3 | en_GB |
Files in this item
This item appears in the following Collection(s)
-
WWMM
The WorldWideMolecularMatrix, an Open collection of information on small molecules